PT-141

About PT-141

PT-141, also known as Bremelanotide, represents a groundbreaking advancement in peptide research focused on sexual health and function. Originally developed from the tanning peptide Melanotan II, researchers discovered its unique ability to work through the central nervous system rather than the vascular system, making it a subject of intense scientific interest for studying desire and arousal pathways.

This synthetic peptide works by activating melanocortin receptors in the brain, particularly MC3R and MC4R, which are involved in regulating sexual response and behavior. Unlike other compounds that work on blood flow, PT-141 targets the neurological pathways associated with sexual desire, making it a valuable tool for researchers studying the complex mechanisms of human sexuality and arousal.

Clinical research has demonstrated PT-141's potential applications in both male and female subjects, with studies showing promising results in addressing various aspects of sexual dysfunction. The peptide has been extensively studied in controlled trials, with researchers documenting its effects on desire, arousal, and overall sexual satisfaction. Its unique mechanism of action has opened new avenues for understanding the neuroscience of sexual function.

For research purposes, PT-141 is typically administered subcutaneously, with effects observed within 45 minutes to 2 hours post-administration. Researchers appreciate its relatively targeted action and the wealth of clinical data available from previous studies. This peptide continues to be an important tool for scientists investigating sexual health, neuroendocrine function, and melanocortin receptor pathways.

For research use only. Not for human or veterinary use, consumption, or therapeutic application.